PTC-209
SIGMA/SML1143 - ≥98% (HPLC)
Synonym: N-
CAS Number: 315704-66-6
Empirical Formula (Hill Notation): C17H13Br2N5OS
Molecular Weight: 495.19
MDL Number: MFCD02110649
Linear Formula: C17H13Br2N5OS
Product Type: Chemical
assay | ≥98% (HPLC) |
color | white to brown |
form | powder |
InChI | 1S/C17H13Br2N5OS/c1-9-15( |
InChI key | XVOOCQSWCCRVDY-UHFFFAOYSA |
Quality Level | 100 |
SMILES string | BrC1=CC(OC)=CC(Br)=C1NC2= |
solubility | DMSO: 20 mg/mL, clear |
storage temp. | 2-8°C |
Application: | PTC-209 has been used as a B lymphoma Mo-MLV insertion region 1 homolog (BMI1) inhibitor to study its effects on: • the cell viability of canine osteosarcoma (OSA) cell lines • lipidated microtubule-associated protein 1 light chain 3 (LC3B-II) and Sequestosome 1 (SQSTM1) protein levels in ovarian cancer (OvCa) cells • cardiac reprogramming efficiency in mouse embryonic fibroblasts (MEF) |
Biochem/physiol Actions: | PTC-209 inhibits the expression of the oncogene BMI-1 (B lymphoma Mo-MLV insertion region 1 homolog), which encodes a polycomb group RING finger protein involved in cell cycle. PTC-209 lowers the self-renewal properties of colorectal cancer-initiating cells (CICs) The compound inhibits tumor growth, and reduces the levels of CICs present in colon cancer tumor xenografts in mice. |
Features and Benefits: | This compound is a featured product for Gene Regulation research. Click here to discover more featured Gene Regulation products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm . |
Packaging: | 5, 25 mg in glass bottle |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Purity | ≥98% (HPLC) |
Storage Temp. | 2-8°C |
UNSPSC | 12352200 |